阿司匹林联合缓释型双嘧达莫防治急性缺血性脑卒中后脑血管缺血的疗效观察

The Observation of Aspirin Combined with Sustained-release Dipyridamole in the Prevention and Treatment of Cerebral Ischemia after Acute Ischemic Stroke

目的探讨阿司匹林联合缓释型双嘧达莫防治急性缺血性脑卒中后脑血管缺血治疗效果及应用价值。方法选择该院治疗的急性缺血性脑卒中患者100例,随机均分为两组,每组50例,对照组采用阿司匹林进行防治,观察组在对照组基础上联合使用双嘧达莫进行防治,观察两组临床疗效。结果观察组优于对照组,差异有统计学意义(P<0.05)。结论采用阿司匹林联合缓释型双嘧达莫可以改善脑缺血患者神经认知功能,同时还具有预防再次缺血事件的发生,值得在临床上大力推广使用。

Objective To investigate the therapeutic effect and application value of aspirin and sustained-release dipyridamole in the prevention and treatment of cerebral ischemia after acute ischemic stroke. Methods 100 patients with acute ischemic stroke were randomly divided into two groups with 50 patients in each. The control group was treated with aspirin for prevention and treatment, while the observation group was treated with dipyridamole on the basis of aspirin. And the clinical efficacy of two groups was observed. Results The efficacy of the observation group was better than that of the control group, the difference was statistically significant（P 〈0.05）. Conclusion Aspirin combined with sustained-release dipyridamole can improve the cognitive function of the patients with cerebral ischemia, and prevent the recurrence of cerebral ischemia, which is worthy of vigorously clinical promotion.